Clinical trial
Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial…
NCT00050765 · Bioheart, Inc., Industry · Unknown status
Key facts
| NCT number | NCT00050765 |
|---|---|
| Title | Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection |
| Official title | A Phase I Multi-Center Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation in Patients With a Previous MI and Placement of an ICD Requiring De Novo Coronary Artery Bypass Graft Therapy |
| Lead sponsor | Bioheart, Inc., Industry |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Congestive Heart Failure, Coronary Artery Disease, Myocardial Infarction |
| Intervention type | Drug |
| Interventions | MyoCell™ Autologous Myoblasts |
| Enrollment | 15 |
| Start date | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Dec 19, 2002 |
| Last update posted | Mar 8, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: